A NEW POSSIBILITY FOR WEIGHT REGULATION?

Experts are excitedly investigating retatrutide, a novel treatment developed by Eli Lilly, as a possible step in body loss . Unlike many existing approaches, retatrutide is a dual -action compound targeting equally GLP-1 and GIP, substances that impact appetite and blood glucose control . Prelim